Proteolytic Activation Transforms Heparin Cofactor II into a Host Defense Molecule
Autor: | Artur Schmidtchen, Douglas M. Tollefsen, Gopinath Kasetty, Martina Kalle, Praveen Papareddy, Matthias Mörgelin, Martin Malmsten |
---|---|
Rok vydání: | 2013 |
Předmět: |
Conformational change
Infectious Disease and Host Response Proteolysis Blotting Western Immunology Peptide Biology Epitope Serine Mice Thrombin medicine Animals Humans Immunology and Allergy Chromatography High Pressure Liquid Mice Knockout Heparin cofactor II chemistry.chemical_classification Innate immune system medicine.diagnostic_test Flow Cytometry Mice Inbred C57BL Biochemistry chemistry Heparin Cofactor II Electrophoresis Polyacrylamide Gel Antimicrobial Cationic Peptides medicine.drug |
Zdroj: | The Journal of Immunology. 190:6303-6310 |
ISSN: | 1550-6606 0022-1767 |
DOI: | 10.4049/jimmunol.1203030 |
Popis: | The abundant serine proteinase inhibitor heparin cofactor II (HCII) has been proposed to inhibit extravascular thrombin. However, the exact physiological role of this plasma protein remains enigmatic. In this study, we demonstrate a previously unknown role for HCII in host defense. Proteolytic cleavage of the molecule induced a conformational change, thereby inducing endotoxin-binding and antimicrobial properties. Analyses employing representative peptide epitopes mapped these effects to helices A and D. Mice deficient in HCII showed increased susceptibility to invasive infection by Pseudomonas aeruginosa, along with a significantly increased cytokine response. Correspondingly, decreased levels of HCII were observed in wild-type animals challenged with bacteria or endotoxin. In humans, proteolytically cleaved HCII forms were detected during wounding and in association with bacteria. Thus, the protease-induced uncovering of cryptic epitopes in HCII, which transforms the molecule into a host defense factor, represents a previously unknown regulatory mechanism in HCII biology and innate immunity. |
Databáze: | OpenAIRE |
Externí odkaz: |